Market Place
Sourcing Support
Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics
10 Jul 2023 //
BUSINESSWIRE
Menarini and SciClone Sign Agreement to Develop and Commercialize Vaborem
21 Sep 2022 //
PRNEWSWIRE
MENARINI RICERCHE ANNOUNCES THE LATEST FINDINGS OF ITS VABOREM™
09 Jul 2020 //
PRESS RELEASE
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
New medicine to treat infections in adults
22 Sep 2018 //
EMA
CHMP Backs 13 New Medicines, Maintains Negative Opinion of Sarepta’s Exondys
21 Sep 2018 //
RAPS
Melinta`s Vabomere (meropenem,vaborbactam) Granted New Tech Add-On Paymt by CMS
03 Aug 2018 //
GLOBENEWSWIRE
Melinta Therapeutics Announces Closing of Underwritten Public Offering
29 May 2018 //
PRESS RELEASE
Melinta Presents Results from VABOMERE TANGO II Trial at ECCMID 2018
23 Apr 2018 //
PRESS RELEASE
Melinta to Highlight Commitment to Antibiotics and Product Portfolio
08 Mar 2018 //
PRESS RELEASE
Melinta Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™
27 Feb 2018 //
PRESS RELEASE
Melinta Completes Acquisition of The Medicines Company’s
08 Jan 2018 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.